Navigation Links
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Date:8/14/2009

-- (276,775) Prepaid expenses and other receivables (2,799,533) (336,134) Accounts payable and accrued expenses 103,336 992,489 Customer and other deposits 109,774 17,218 VAT tax payable 390,657 102,520 Income tax payable 946,113 46,484 Net cash provided by (used in) operating activities 1,188,691 (1,673,872) CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property and equipment (439) (21,778) Net cash provided by (used in) Investing activities (439) (21,778) CASH FLOWS FROM FINANCING ACTIVITIES Net cash provided by (used in) financing activities -- -- Effect of exchange rate changes on cash and cash equivalents 128 103,769 Net Increase (Decrease) in cash and cash equivalents 1,188,380 (1,591,881) Cash and cash equivalents, beginning balance 758,316 2,286,419 Cash and cash equivalents, ending balance $1,946,696 $694,538 SUPPLEMENTAL DISCLOSURES: Interest payments $-- $29,344 Income tax payments $480,620 $482,992
'/>"/>
SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
3. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
4. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
5. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
9. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
10. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... with State Biotech Leaders to Develop Blueprint ... Development while Boosting Rhode Island,s Growing Biotech ... R.I., Dec. 14 Several of ... medicine and biotechnology gathered today at Brown ... importance of medical innovation in Rhode Island ...
(Date:12/14/2009)... Dec. 14 Nektar Therapeutics (Nasdaq: ... been appointed to serve on its board of ... leader with over 35 years of experience in ... brings to Nektar extensive industry perspective at an ... W. Robin, President and CEO of Nektar and ...
(Date:12/11/2009)... -- EntreMed, Inc. (Nasdaq: ENMD ), today ... revenue from sales of Thalomid® during the third ... million. In addition, the Company anticipates a ... fiscal 2009. The difference in estimated and ... reflected in the fourth quarter financial results. ,, ...
(Date:12/11/2009)... have observed the "hot electron" effect in a solar ... elusive charges using ultra-thin solar cells, opening a potential ... in the current online edition of Applied Physics ... cells, it generates free electrons in a range of ... the electrons must reach the bottom of the conduction ...
Breaking Biology Technology:Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3EntreMed Reports Receipt of Third Quarter Royalty Payment 2Elusive 'hot' electrons captured in ultra-thin solar cells 2
... 2 "The federal government,s ability to,more exactly measure the ... a great statistical tool -- but that is all that ... us that HIV/AIDS continues,to be a real public health problem ... the globe. Despite recent setbacks in developing,an effective vaccine to ...
... at 9:30 a.m., SUNRISE, Fla., Aug. 1 ... Chairman and CEO of,Bioheart, will present a corporate overview ... Red Chip Investor Conference at the Marriott,Marquis in New ... be,available via the internet by visiting and registering to ...
... Aug. 1 Novavax, Inc. (Nasdaq:,NVAX) announced today ... equity financing of $18 million by issuing common ... registration statement.,The Company sold 6,686,650 units to certain ... the Company. Each unit was comprised,of one share ...
Other Biology Technology:Bioheart, Inc. to Present at Red Chip Investor Conference in New York 2Novavax Announces Closing of $18 Million Registered Direct Offering 2Novavax Announces Closing of $18 Million Registered Direct Offering 3
(Date:12/14/2009)... the Biomedical Engineering Society (BMES) have founded a new ... ). CVET is a forum for ... treatment. The first issue of the new quarterly ... other BMES publications at Springer, Annals of Biomedical ... , Cardiovascular Engineering and Technology will present ...
(Date:12/14/2009)... of the United Nations Framework Convention on Climate ... Agency hosted the ,Bend the Trend, event on ... platform and premiere the screening of the new ... of Europe, a joint project of the European ... and ESA, is a series of short films ...
(Date:12/13/2009)... team led by Yale University researchers has used ... for the first time. Their findings, which appear ... Nature Nanotechnology , could dramatically simplify the ... other diseases. , The teamled by ... & Applied Science, and Tarek Fahmy, an associate ...
Breaking Biology News(10 mins):Biomedical Engineering Society's new journal to be published by Springer 2'Environmental Atlas of Europe' unveiled at COP15 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2WellPoints Contribution To Drug Formulary Evaluation Standards Highlighted in ISPOR Publication 50651 1WellPoints Contribution To Drug Formulary Evaluation Standards Highlighted in ISPOR Publication 50651 2WellPoints Contribution To Drug Formulary Evaluation Standards Highlighted in ISPOR Publication 50651 3Pennsylvania DEP Lehigh Valley Berks County Air Quality Partnership Urge Public Transit Use 50648 1Pennsylvania DEP Lehigh Valley Berks County Air Quality Partnership Urge Public Transit Use 50648 2American Society of Medical Doctors Established to Protect the Bond Between Physicians and Patients 3B Organizing Doctors to Oppose Government Run Hea 50645 1American Society of Medical Doctors Established to Protect the Bond Between Physicians and Patients 3B Organizing Doctors to Oppose Government Run Hea 50645 2
... remains the most desired tool to combat the worsening ... colleagues (from the Institut Pasteur in Paris) have completed ... MSP3, a protein present on the surface of the ... As the researchers report in the international open-access medical ...
... University researchers have invented a process for uncoiling long ... , Ultimately, these DNA strands could act as wires ... James Lee, professor of chemical and biomolecular engineering at ... of the Proceedings of the National Academy of Sciences, ...
... harmless E. coli bacterium, which has one-seventh the number ... of them involved in metabolism and metabolic regulation. Activation ... capable of generating a huge variety of internal states; ... 27 issue of Proceedings of the National Academy of ...
Other Biology News:Researchers make long DNA 'wires' for future medical and electronic devices 2How E. coli bacterium generates simplicity from complexity 2How E. coli bacterium generates simplicity from complexity 3
Immunochemistry 1 & 2...
...
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
Biology Products: